Hear more from Dr. Loewen.
1.What are the key technological differences to be aware of when purchasing an ophthalmic microscope?
2. In your opinion, what is the ideal ophthalmic operating microscope?
3. Why is Xenon the preferred light source option for the UPMC Eye Center?
4. Why is it important to have a microscope with both apochromatic lenses and a short stack?
Please send any questions for Dr. Loewen or Dr. Lagouros to EyeCenter@upmc.edu.
John Fowler, MD, a hand and upper extremity surgeon at UPMC, recently gave a presentation at the annual meeting of the American Academy of Orthopaedic Surgeons. Dr. Fowler’s presentation compared the use ultra sound and nerve testing in the diagnosis of carpal tunnel.
Hear more from Dr. Fowler.
Christopher Harner, MD, medical director of the UPMC Center for Sports Medicine, presented at the American Academy of Orthopaedic Surgeons annual meeting in March. Dr. Harner’s presentation focused on meniscal allograft transplantation, specifically indications, techniques, and outcomes.
Learn more about Dr. Harner’s presentation.
James Kang, MD, presented two lectures at this year’s American Academy of Orthopaedic Surgeons annual meeting in New Orleans. The first lecture focused on cervical spinal deformities and how to surgically treat those patients. The second lecture looked at cervical myelopathy. This lectured specifically discussed how to manage those cases and complications that may arise.
Learn more about Dr. Kang’s presentations.
This year at the American Academy of Orthopaedic Surgeons annual meeting Mark Baratz, MD, gave an instructional course on distal radius fractures. The course focused on the decision of when to operate and which patients benefit from surgery.
Learn more about Dr. Baratz’s presentation.
At the 2014 annual meeting of the American Academy of Orthopaedic Surgeons, Ivan Tarkin, MD, chief of orthopaedic traumatology at UPMC, served as the chairman of the Trauma Program Committee. As chairman, Dr. Tarkin had the opportunity to present at the best of AAOS. His presentation highlighted research on best care paradigms for three common orthopaedic injuries.
In this month’s News You Can Use column in Ocular Surgery News, Joesph Martel, MD, discussed the changes and new strategies in treatment for massive submacular hemorrhage. Dr. Martel’s full article is available on the Ocular Surgery News site.
How has the treatment of SMH changed?
What are the forces dictating whether SMH displacement will occur?
How is the use of subretinal air used in SMH management?
What benefits are there to decreasing SMH buoyancy to the lowest possible degree?
Please send any follow up questions for Dr. Martel to EyeCenter@upmc.com
According to a multidisciplinary team led by scientists at the University of Pittsburgh Cancer Institute (UPCI), invasive lobular carcinoma (ILC), the second-most common type of breast cancer, appears to be a good candidate for a personalized approach to treatment.
Patients with ILC are typically treated with surgery and chemotherapy or hormone therapy, or both. According to Steffi Oesterreich, PhD, professor at UPCI, partner with UPMC CancerCenter, and director of education at the Women’s Cancer Research Center, a subset of patients with ILC receive less benefit from this treatment than those with ductal carcinoma.
These findings were recently published in the March 1 edition of Cancer Research.
Watch Dr. Oesterreich and Matthew Sikora, PhD, a postdoctoral associate at UPCI, discuss this study.
Read more about this study.
Glaucoma is the world’s second leading cause of blindness. In recognition of that, the World Glaucoma Association has named March 9-15 World Glaucoma Week. This is a week dedicated to encouraging everyone to find out if they are at risk.
Joel S. Schuman, MD, FACS, and his team have been working on a way to diagnose glaucoma earlier. Dr. Schuman’s team has been using Optical Coherence Tomography (OCT) to detect early abnormalities in the optic nerve that occur before the change is detectable in the vision field. This development enables ophthalmologists to diagnose glaucoma earlier than ever before, allowing for better treatment and the possibility of slowing disease progression.
Learn more from Dr. Schuman about how OCT testing is being used to detect glaucoma.
Send any follow up questions for Dr. Schuman to EyeCenter@upmc.edu.